#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15252	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2522	743.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1608	1608	C	964	C	964	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15252	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2522	743.3	0	HET	.	.	.	G993C	.	993	993	G	1417	1417	G	974	G,C	740,234	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15252	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2522	743.3	0	HET	.	.	.	A726G	.	726	726	A	1150	1150	A	916	A,G	728,188	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25786	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4202	766.3	0	.	n	.	0	T695C	SNP	695	695	T	1333	1333	C	918	C,T,A,G	913,2,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25786	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4202	766.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1975	1975	A	1073	A,T	1072,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25786	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4202	766.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2609	2609	C	909	C,T	908,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25786	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4202	766.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2683	2683	A	858	A,G	857,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25786	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4202	766.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3235	3235	C	887	C	887	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	27	2306	folP	852	852	100.0	folP.l15.c17.ctg.1	2082	138.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1336	1338	AGC	247;247;247	A,T;G,A;C,T	246,1;246,1;246,1	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5830	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3880	187.6	1	SNP	p	S91F	0	.	.	271	273	TCC	840	842	TCC	210;210;208	T;C;C	210;210;208	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5830	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3880	187.6	1	SNP	p	D95G	0	.	.	283	285	GAC	852	854	GAC	216;217;215	G,T;A;C	214,2;217;215	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5830	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3880	187.6	1	SNP	p	D95N	0	.	.	283	285	GAC	852	854	GAC	216;217;215	G,T;A;C	214,2;217;215	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	2128	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1849	143.6	1	SNP	p	G45D	0	.	.	133	135	GGC	734	736	GGC	240;244;244	G;G;C	239;243;244	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1138	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1450	97.7	0	.	n	.	0	A197.	DEL	197	197	A	765	765	A	222	A	222	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5128	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3391	188.4	1	SNP	p	D86N	0	.	.	256	258	GAC	807	809	GAC	226;226;225	G;A;C	226;226;225	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5128	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3391	188.4	1	SNP	p	S88P	0	.	.	262	264	TCC	813	815	TCC	222;221;222	T;C;C	222;221;222	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4540	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3213	176.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1784	1786	GGC	274;275;273	G;G;C,A	274;275;272,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4132	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2995	172.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1551	1553	GCA	247;252;251	G;C;A	247;252;251	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4132	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2995	172.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1554	1556	ATC	252;253;254	A;T,C;C,G	252;252,1;252,2	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4132	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2995	172.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1566	1568	GTG	239;236;237	G;T,C;G	239;235,1;237	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4132	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2995	172.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1566	1568	GTG	239;236;237	G;T,C;G	239;235,1;237	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4132	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2995	172.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2070	2072	ACC	247;245;246	A,C;C;C	246,1;245;246	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4132	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2995	172.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2124	2126	GCG	221;222;220	G;C;G	221;222;220	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4132	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2995	172.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2124	2126	GCG	221;222;220	G;C;G	221;222;220	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4132	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2995	172.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2247	2249	GGC	221;223;224	G,C;G,A;C,G	220,1;222,1;223,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4132	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2995	172.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2256	2258	GGC	216;220;220	G,A;G;C,T,A	215,1;220;218,1,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4132	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2995	172.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2274	2276	CCG	223;224;221	C,G;C;G,C	222,1;224;220,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5582	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3682	189.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1980	1982	CCG	209;207;207	C;C;G	209;207;207	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2530	porA	1146	1146	99.83	porA.l15.c30.ctg.1	2494	126.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	704	706	GGC	186;188;187	G;G;C	186;188;187	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2530	porA	1146	1146	99.83	porA.l15.c30.ctg.1	2494	126.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	886	886	C	199	C,T	198,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2874	porB1b	1047	1047	98.85	porB1b.l15.c30.ctg.1	1681	206.9	0	.	p	.	0	A26T	NONSYN	76	78	GCC	578	580	ACC	256;255;256	A,G;C;C	254,2;255;256	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2874	porB1b	1047	1047	98.85	porB1b.l15.c30.ctg.1	1681	206.9	0	.	p	.	0	D41K	NONSYN	121	123	GAC	623	625	AAA	273;273;277	A,C;A;A	272,1;273;277	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2874	porB1b	1047	1047	98.85	porB1b.l15.c30.ctg.1	1681	206.9	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	860	862	AAG	233;236;234	A;A;G,C	233;236;233,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2874	porB1b	1047	1047	98.85	porB1b.l15.c30.ctg.1	1681	206.9	0	.	p	.	0	V215F	NONSYN	643	645	GTT	1145	1147	TTT	256;251;251	T;T;T	256;250;250	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2874	porB1b	1047	1047	98.85	porB1b.l15.c30.ctg.1	1681	206.9	0	.	p	.	0	D294S	NONSYN	880	882	GAT	1382	1384	AGT	220;225;226	A;G;T	220;225;226	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2874	porB1b	1047	1047	98.85	porB1b.l15.c30.ctg.1	1681	206.9	1	SNP	p	D121N	0	.	.	361	363	GAC	863	865	GAC	235;237;237	G;A;C	235;237;237	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2874	porB1b	1047	1047	98.85	porB1b.l15.c30.ctg.1	1681	206.9	1	SNP	p	A121D	1	.	.	361	363	GAC	863	865	GAC	235;237;237	G;A;C	235;237;237	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10008	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5243	238.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1468	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1816	101.0	1	SNP	p	V57M	1	.	.	169	171	ATG	973	975	ATG	244;246;247	A;T;G	244;246;247	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
